# RPM_AI_OUTPUT_ESCALATION_AND_REVIEW.md

## 1. Purpose
This document defines the mandatory escalation and review process for AI-assisted outputs generated within the NeuroGrid Remote Patient Monitoring (RPM) system. Its purpose is to ensure patient safety, clinical accountability, and regulatory compliance by enforcing human oversight over all AI-derived signals with potential clinical impact.

## 2. Scope
This protocol applies to all AI-assisted RPM outputs, including:
- Risk stratification scores
- Alerts and notifications
- Trend analyses
- Predictive warnings
- Anomaly interpretations
- Decision-support recommendations

No AI output is exempt from this protocol.

## 3. Core Principles
- AI outputs are advisory, not determinative
- Human clinical judgment is final
- Uncertainty must trigger escalation, not automation
- Safety overrides efficiency
- Every escalated output must be traceable and reviewable

## 4. AI Output Classification

### Level 1 – Informational
- No immediate clinical relevance
- Contextual or observational output
- Logged without escalation

### Level 2 – Advisory
- Potential clinical relevance
- Requires clinician awareness
- No mandatory action required

### Level 3 – Action-Suggestive
- Suggests possible intervention
- Requires explicit human review
- Cannot trigger autonomous action

### Level 4 – High-Risk
- Indicates potential patient harm
- Requires immediate escalation
- Triggers safety and oversight protocols

## 5. Escalation Triggers
Escalation is mandatory when:
- Output confidence falls outside approved thresholds
- Model behavior deviates from expected patterns
- Conflicting outputs are generated
- Output contradicts known clinical context
- High-risk classification is assigned
- Clinician flags or disputes the output

Failure to escalate constitutes a system breach.

## 6. Immediate Handling Rules
Upon escalation:
- Output is clearly labeled as AI-assisted
- Downstream automation is halted
- Clinicians are notified of escalation status
- Human review is required before any action

Unsafe outputs must never propagate unreviewed.

## 7. Escalation Pathway
Escalation proceeds as follows:
- Level 2: Clinician notification and optional review
- Level 3: Mandatory clinician review and acknowledgment
- Level 4: Immediate escalation to clinical oversight and safety lead

Escalation timelines are enforced and auditable.

## 8. Review Authority
Reviews are conducted by:
- Authorized clinicians
- Clinical oversight committee (for high-risk cases)
- Safety Council where systemic risk is suspected

Reviewers must be appropriately qualified and independent.

## 9. Review Inputs
Each review must include:
- Output ID and timestamp
- Model identifier and version
- Input data lineage reference
- Confidence score and thresholds
- Explanation artifact
- Contextual clinical data
- Human decision taken

Incomplete reviews are invalid.

## 10. Review Outcomes
Possible outcomes include:
- Output accepted and acted upon
- Output acknowledged with no action
- Output modified by human judgment
- Output rejected
- Model behavior flagged for investigation

Outcomes must be explicitly recorded.

## 11. Model Escalation
If repeated or severe issues are detected:
- Model confidence thresholds may be adjusted
- Model outputs may be restricted
- Model deployment may be suspended
- Formal audit or safety case review may be triggered

Model escalation decisions are governance-controlled.

## 12. Clinician Disagreement
Clinicians may formally disagree with AI outputs:
- Disagreements are logged
- No penalty or retaliation is permitted
- Patterns of disagreement trigger model review

Disagreement is a safety signal, not a failure.

## 13. Documentation and Logging
All escalations and reviews are:
- Logged immutably
- Timestamped
- Linked to model versions and data
- Retained per governance policy

Missing logs constitute a compliance failure.

## 14. Transparency and Disclosure
Escalation statistics and systemic findings:
- Are available to oversight bodies
- May be disclosed publicly where required
- Inform ongoing system improvement

Individual patient data remains protected.

## 15. Regulatory Alignment
This protocol aligns with:
- EU AI Act human oversight requirements
- FDA Good Machine Learning Practice
- Clinical decision-support governance standards
- ISO/IEC AI risk management guidance

## 16. Status
Active – Mandatory RPM AI Output Escalation and Review Protocol
